Consonance Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,155,793
| Closed | -$11M | – | 32 |
|
|
2018
Q4 | $11M | Sell |
1,155,793
-1,591,405
| -58% | -$15.1M | 0.81% | 19 |
|
|
2018
Q3 | $45.6M | Hold |
2,747,198
| – | – | 2.46% | 18 |
|
|
2018
Q2 | $44.1M | Buy |
2,747,198
+140,600
| +5% | +$2.26M | 2.84% | 16 |
|
|
2018
Q1 | $39.9M | Buy |
2,606,598
+256,806
| +11% | +$3.93M | 3.64% | 12 |
|
|
2017
Q4 | $36.7M | Buy |
2,349,792
+2,248,372
| +2,217% | +$35.1M | 3.31% | 13 |
|
|
2017
Q3 | $1.13M | Buy |
+101,420
| New | +$1.13M | 0.12% | 18 |
|